Kevin Hallgren, PhD
Personal Statement
I am a clinical psychologist with research interests in the treatment of alcohol and substance use disorders and co-occurring mental health conditions. My research focuses on understanding how to improve access to evidence-based treatments and understanding why and how patients benefit from treatment. I am particularly interested in research measurement-based care — i.e., the use of standardized measures to monitor treatment progress and inform clinical decision-making. Broad areas of interest include:- Alcohol and drug use disorder treatment, including the effectiveness of digital and behavioral interventions, mechanisms of behavioral change, and social and environmental determinants of change.
- Technology to support behavioral change, including patient- and clinician-facing tools that support clinical decision-making, treatment adherence, and treatment progress monitoring.
- Applied statistical analysis, including methods for analyzing longitudinal data, clinical trials data, multilevel data, missing data, psychometric analysis, and data visualization.
Education
PhD, Clinical Psychology, University of New Mexico, 2010-2014
Pre-Doctoral Psychology Internship, Southwest Consortium of Clinical Psychology Internships, 2013-2014
MS, Psychology, University of New Mexico, 2008-2010
BA, Psychology, University of Missouri, 2003-2007
Department Affiliations
Centers/Programs
Other Affiliations
Scholarly Expertise
- Access to health care
- Addiction
- Addiction psychiatry/psychology
- Alcohol Use Disorder (AUD)
- Biostatistics
- Collaborative Care / Integrated Care
- Depression
- Evidence-based practice
- Health behaviors
- Health services and health policy
- Human-centered design
- Implementation science
- Measurement-based care
- Medical records
- Mobile mental health
- Opioid Use Disorder (OUD)
- Patient-centered outcomes
- Pragmatic clinical trials
- Primary care
- Psychosocial outcomes
- Psychotherapies
- Randomized controlled trial
- Research methods
- Telemedicine
- Telepsychiatry/telepsychology
- Improving recognition of alcohol use disorders in Veterans Health Administration primary care through implementation of standardized symptom assessment
- Developing person-specific signatures of momentary risk for alcohol use
- Improving treatment strategies and clinical outcomes in patients with first-episode psychosis and substance use disorders
- Developing a hospital-based treatment engagement program for Alcohol Use Disorder
- Validating changes in a primary-care based alcohol use screening instrument for predicting changes in risk for psychiatric acute care utilization
- Partnering with the Quinault Indian Nation to develop a community-based contingency management intervention
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Acceptability and feasibility of a single-session + digital mental health intervention for people with psychosis on an acute psychiatric inpatient unit
- eHaRT-A: adapting an in-person harm reduction for alcohol intervention into a telehealth platform
- eHaRT-A
- Impact of the Preventing Addiction-Related Suicide (PARS) Intervention on patients who receive community-based addiction treatment
- Using routine alcohol screening measures to identify 1-year risk of suicidal ideation, intent, and planning within a large primary care system in Washington
- Understanding practical alcohol measures in primary care to prepare for measurement-based care
- Improving opioid use disorder treatment using contingency management via mHealth
- Developing measurement-based care tools for addiction treatment clinics
- Bolster: Development and testing of a caregiver-facing mobile health intervention to reduce duration of untreated psychosis
- Feasibility of mHealth technology-enabled service for remote observed therapy of methadone and COVID-19 screening for patients in an opioid treatment program
- The UW Medical Student Addiction Research (MedStAR) program to address substance use disorders in urban and rural communities in five western states
- Patient-centered team-based primary care to treat opioid use disorder, depression, and other conditions (PC2Too)
- Changing our paths: well-being and recovery among Native Americans with opioid use disorder
- Alcohol and addiction Research Domain Criteria (AARDoC) and alcohol use disorder recovery
- Validating a DSM-5 Substance Use Disorder (SUD) symptom checklist
Recent Publications
Patient Navigation Plus mHealth Incentives for Linkage to OUD Care for Adults Who Also Use Methamphetamines: A Pilot Randomized Clinical Trial.
(2026 Oct 1)
JAMA Netw Open 9(10): e2638542
Bhatraju EP, Zinsli KA, Kennedy DN, Gojic AJ, Iles-Shih M, Merrill JO, Speaker EC, Samet JH, Hallgren KA, Tsui JI
(2026 Oct 1)
JAMA Netw Open 9(10): e2638542
Bhatraju EP, Zinsli KA, Kennedy DN, Gojic AJ, Iles-Shih M, Merrill JO, Speaker EC, Samet JH, Hallgren KA, Tsui JI
Patient Travel Experiences for Methadone Dosing Visits.
(2026 Oct 1)
JAMA Netw Open 9(10): e2637601
Austin EJ, Ravi V, Gojic AJ, Bhatraju EP, Darnton J, Grekin P, Soth S, Woolworth S, Hallgren KA, Tsui JI, Williams EC
(2026 Oct 1)
JAMA Netw Open 9(10): e2637601
Austin EJ, Ravi V, Gojic AJ, Bhatraju EP, Darnton J, Grekin P, Soth S, Woolworth S, Hallgren KA, Tsui JI, Williams EC
A Retrospective Cohort Study of Hospitalised Patients With First-Episode Substance-Induced Psychosis and First-Episode Psychosis: Comparing Long-Acting Injectable Antipsychotic Use and Post-Discharge Outcomes.
(2026 Sep)
Early Interv Psychiatry 20(9): e70250
Eun JD, Iles-Shih M, Ren S, Hallgren KA, Kuczynski A
(2026 Sep)
Early Interv Psychiatry 20(9): e70250
Eun JD, Iles-Shih M, Ren S, Hallgren KA, Kuczynski A
Synchrony in therapist's and patient's vocally encoded arousal and its association with the quality of the therapeutic relationship.
(2026 Jun 22)
Psychother Res
Blanc S, Hallgren KA, Gaume J
(2026 Jun 22)
Psychother Res
Blanc S, Hallgren KA, Gaume J
Association of unhealthy alcohol use reported in routine outpatient screening with 30-day hospital readmission risk.
(2026 Sep)
J Subst Use Addict Treat 188(): 209984
Kasinathan B, Matson TE, Oliver M, Bobb JF, Berger D, Hallgren KA, Jack HE
(2026 Sep)
J Subst Use Addict Treat 188(): 209984
Kasinathan B, Matson TE, Oliver M, Bobb JF, Berger D, Hallgren KA, Jack HE
Show complete publication list »
